Weiwei Fu
Impact in
-
- Acupuncture Treatment Research Studies
-
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
Papers in
- Genetics 6
- Glioma Diagnosis and Treatment 6
- Genetic and phenotypic traits in livestock 1
- Co-authors
- Xuezhu Zhang (1 shared paper)Jingxian Han (1 shared paper)Tong Wang (1 shared paper)Jianchun Yu (1 shared paper)Cun‐Zhi Liu (1 shared paper)Mei Qi (3 shared papers)Bo Han (3 shared papers)Chunni Wang (2 shared papers)
- Journals
- Disease Markers (2 papers)Molecular Carcinogenesis (1 paper)World Neurosurgery (1 paper)The Prostate (1 paper)Advanced Science (1 paper)
- Partner nations
- ChinaUnited KingdomUnited States
In The Last Decade
Weiwei Fu
19 papers receiving 361 citations
Peers
Comparison fields: 5 of 63
- Complementary and alternative medicine 63
- Cancer Research 95
- Geriatrics and Gerontology 17
- Neurology 30
- Oncology 78
Countries citing papers authored by Weiwei Fu
This map shows the geographic impact of Weiwei Fu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weiwei Fu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weiwei Fu more than expected).
Fields of papers citing papers by Weiwei Fu
This network shows the impact of papers produced by Weiwei Fu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weiwei Fu. The network helps show where Weiwei Fu may publish in the future.
Co-authors
The 25 scholars most cited alongside Weiwei Fu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2005 | 78 | |
| 2 | 2015 | 53 | |
| 3 | 2014 | 52 | |
| 4 | 2018 | 49 | |
| 5 | 2020 | 45 | |
| 6 | 2014 | 27 | |
| 7 | 2019 | 14 | |
| 8 | 2021 | 8 | |
| 9 | Thyroid-like Follicular Carcinoma of the Kidney and Papillary Renal Cell Carcinoma with Thyroid-like Feature: Comparison of Two Cases and Literature Review. | 2015 | 8 |
| 10 | 2018 | 7 | |
| 11 | 2021 | 6 | |
| 12 | Primary meningeal melanocytoma located in foramen magnum: a case report and review of the literatures. | 2012 | 6 |
| 13 | 2020 | 5 | |
| 14 | 2022 | 5 | |
| 15 | 2024 | 2 | |
| 16 | 2017 | 1 | |
| 17 | 2025 | 1 | |
| 18 | 2020 | 1 | |
| 19 | 2021 | 1 | |
| 20 | 2025 | 0 |
About Weiwei Fu
Weiwei Fu is a scholar working on Molecular Biology, Genetics, Pulmonary and Respiratory Medicine, Surgery and Epidemiology, having authored 20 papers that have together received 369 indexed citations. Recurring topics across this work include Glioma Diagnosis and Treatment (6 papers), Prostate Cancer Treatment and Research (3 papers), Meningioma and schwannoma management (2 papers), Hippo pathway signaling and YAP/TAZ (2 papers), Neuroendocrine Tumor Research Advances (2 papers), MicroRNA in disease regulation (1 paper), Genetic and phenotypic traits in livestock (1 paper) and Nanoplatforms for cancer theranostics (1 paper). The work is most often cited by research in Complementary and alternative medicine (63 citations), Cancer Research (95 citations), Geriatrics and Gerontology (17 citations), Neurology (30 citations) and Oncology (78 citations). Weiwei Fu has collaborated with scholars based in China, United Kingdom and United States. Frequent co-authors include Xuezhu Zhang, Jingxian Han, Tong Wang, Jianchun Yu, Cun‐Zhi Liu, Mei Qi, Bo Han, Chunni Wang, Lin Wang and Yujun Li. Their work appears in journals such as Disease Markers, Molecular Carcinogenesis, World Neurosurgery, The Prostate and Advanced Science.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.